OFIX News and Press, Orthofix Medical Inc. From 01/09/24

Net sales of $200.3 million, an increase of 64% on a reported basis and an increase of 8% on a pro forma basis Bone Growth Therapies growth of 15%, marking four consecutive quarters with double-digit net sales increases, and representing the strongest quarter of Bone Growth Therapies ...

2024-01-08 07:35:29 ET More on Orthofix Orthofix Medical: Under New Management Orthofix Medical Inc. (OFIX) Q3 2023 Earnings Call Transcript Orthofix appoints three new independent directors Orthofix names Massimo Calafiore as President and Chief Executive Of...

Massimo Calafiore begins as President and Chief Executive Officer, effective immediately Julie Andrews is appointed as Chief Financial Officer, assuming the role effective January 15, 2024 Orthofix Medical Inc . (NASDAQ: OFIX), a leading global spine and orthopedics company, tod...

Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication of new data from a prospective, multicenter study investigating Pulsed Electromagnetic Field (PEMF) stimulation as an adjunct therapy to lumbar spinal fusion procedures in patie...

2023-12-20 23:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-12 07:07:59 ET More on Orthofix Orthofix Medical: Under New Management Orthofix names Massimo Calafiore as President and Chief Executive Officer Orthofix Non-GAAP EPS of $0.07 beats by $0.28, revenue of $184M misses by $1.79M Seeking Alpha’s Qu...

Three New Directors Bring Substantial Finance, Strategic Development, Healthcare and MedTech Experience Orthofix Medical Inc. (NASDAQ: OFIX) (“Orthofix” or the “Company”) today announced the appointment of three new independent directors to the Company’...

NEW YORK, NY / ACCESSWIRE / December 6, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Orthofix Medical Inc ("Orthofix" or "the Company") (NASDAQ:OFIX). Investors who purchased Orthofix securities are encouraged to obtain additional inf...

2023-12-03 07:17:52 ET Summary Orthofix Medical Inc. has had a lackluster performance in 2023 and has brought in a new CEO to turn the company around. The company's orthopedics business segment provides products for orthopedic conditions unrelated to the spine, while its spinal bu...

Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire ...